Indivior
CompanyUnited StatesFounded 1994
Indivior develops 6 assets, the furthest approved (naloxone hydrochloride in opioid overdose). Mostly small molecule acting on OPRM1, OPRK1 and OPRD1; based in the United States, founded in 1994.
- 6
- Assets
- Furthest stage
- Approved
- 31
- Trials
- 26
- Signals
Pipeline
6Blocks opioid receptors, reversing opioid-mediated effects.
Approved, Small molecule, OPRM1, OPRK1, opioid overdose, overdose
Approved
Provides extended-release buprenorphine by subcutaneous injection.
Approved, OPRM1, OPRK1, opioid use disorder, Moderate to Severe Opioid Use Disorder
3 more assets
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms6
- Trials33
- People1
- Signals20
- Similar companies6